|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007097,
umls-concept:C0008838,
umls-concept:C0014871,
umls-concept:C0016360,
umls-concept:C0023413,
umls-concept:C0030705,
umls-concept:C0040808,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0574032,
umls-concept:C1511237,
umls-concept:C1550436,
umls-concept:C1704242,
umls-concept:C1705509
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-4-27
|
|
pubmed:abstractText |
Combination chemotherapy with continuous 5-fluorouracil (5-FU) and cisplatin in a monthly regimen is one of the standard treatments for advanced gastric carcinoma. This study evaluated the new LV5FU2-P regimen, designed to improve efficacy and tolerance of the 5-FU plus cisplatin combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
765-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15111344-Adult,
pubmed-meshheading:15111344-Aged,
pubmed-meshheading:15111344-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15111344-Esophageal Neoplasms,
pubmed-meshheading:15111344-Female,
pubmed-meshheading:15111344-Humans,
pubmed-meshheading:15111344-Infusions, Intravenous,
pubmed-meshheading:15111344-Injections, Intravenous,
pubmed-meshheading:15111344-Male,
pubmed-meshheading:15111344-Middle Aged,
pubmed-meshheading:15111344-Stomach Neoplasms,
pubmed-meshheading:15111344-Survival Analysis,
pubmed-meshheading:15111344-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma.
|
|
pubmed:affiliation |
Hepato-Gastroenterology and Digestive Oncology, CHU Ambroise Paré, 9 Avenue Charles de Gaulle, AP-HP, F-92100 Boulogne-Billancourt, France. emmanuel.mitry@apr.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
